What is NICE Ltd's earnings per share (EPS)?

NICE Ltd (NICE) reported diluted earnings per share of $9.67 for fiscal year 2025. This represents a 43.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

NICE Ltd (NICE) Financials

NICE

FY2025 annual

Revenue $2.9B +7.7% YoY

Net Income $612.1M +39.3% YoY

EPS (Diluted) $9.67 +43.0% YoY

Free Cash Flow $697.6M -12.5% YoY

Market Cap $6.8B as of Oct 7, 2026

Price / Sales 2.3x on $2.9B revenue, FY2025

Price / Earnings 11.0x on $612.1M net income, FY2025

Price / Book 1.7x on $3.9B equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 7, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Feb 26, 2026 Currency USD FYE December

Newest figures come from the 10-K for FY2025, filed Feb 26, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NICE SEC filings page.

NICE Ltd (NICE) reported $2.9B in revenue for fiscal year 2025, up 7.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NICE FY2025 2026-10-03

NICE is converting growth into wider operating margins, but FY2025 earnings outran cash while buybacks and a leaner balance sheet reshaped financing.

Profit-to-cash divergence widened in FY2025: net income rose 39.3% while operating cash flow fell 13.9%, showing that the earnings step-up was not matched by cash generation. Operating-cost leverage is the clearer margin driver: operating margin expanded from 20.0% to 21.9% even as gross margin narrowed slightly.

Liabilities fell from $1.71B in FY2024 to $1.23B in FY2025, while equity reached $3.88B, making the capital structure less debt-dependent. Yet the short-term cushion narrowed: the current ratio slipped from 1.7x to 1.6x as current assets fell to $1.38B.

Buyback effects helped shares outstanding fall 4.4% in FY2025, lifting EPS to $9.67. Because free cash flow fell to $697.6M even as net income rose, the per-share improvement reflects both operating gains and capital allocation, not earnings alone.

Financial Health Signals

Financial Health Score 72/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of NICE Ltd's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

NICE Ltd has an operating margin of 21.9%, meaning the company retains $22 of operating profit per $100 of revenue. This strong profitability earns a score of 85/100, reflecting efficient cost management and pricing power. This is up from 20.0% the prior year.

Growth

NICE Ltd's revenue grew 7.7% year-over-year to $2.9B, a solid pace of expansion. This earns a growth score of 68/100.

Leverage

NICE Ltd carries a low D/E ratio of 0.32, meaning only $0.32 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 68/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

NICE Ltd's current ratio of 1.55 indicates adequate short-term liquidity, earning a score of 44/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

NICE Ltd converts 23.7% of revenue into free cash flow ($697.6M). This strong cash generation earns a score of 91/100.

Returns

NICE Ltd earns a strong 15.8% return on equity (ROE), meaning it generates $16 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 77/100. This is up from 12.2% the prior year.

Altman Z-Score Safe

5.32

NICE Ltd scores 5.32, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($6.8B) relative to total liabilities ($1.2B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

6/8

NICE Ltd passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.17x

For every $1 of reported earnings, NICE Ltd generates $1.17 in operating cash flow ($716.5M OCF vs $612.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt

$379.4M

YoY-21.2%

QoQ-21.2%

NICE Ltd held $379.4M in cash as of Q4 2025; long-term debt is not reported for that period.

Shares Outstanding

60M

YoY-4.5%

QoQ-4.5%

NICE Ltd had 60M shares outstanding in Q4 2025. This represents a decrease of 4.5% from the same quarter a year earlier. Against the prior quarter it is down 4.5%.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

NICE Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NICE quarterly income statement

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$2.9B+7.7%	$2.7B+15.0%	$2.4B+9.0%	$2.2B+13.5%	$1.9B+16.6%	$1.6B+4.7%	$1.6B+9.0%	$1.4B+8.4%	$1.3B+31.2%	$1.0B+9.6%	$926.9M+6.3%	$872.0M+6.1%	$821.5M-6.5%	$879.0M+10.7%	$793.8M
Cost of Revenue	$989.3M+8.8%	$909.5M+18.4%	$768.2M+12.4%	$683.7M+9.5%	$624.5M+11.1%	$562.0M+5.7%	$531.8M+7.0%	$496.8M+6.0%	$468.7M+38.8%	$337.7M+11.2%	$303.6M0.0%	$303.5M+1.3%	$299.6M-14.7%	$351.2M+14.3%	$307.3M
Gross Profit	$2.0B+7.1%	$1.8B+13.4%	$1.6B+7.5%	$1.5B+15.5%	$1.3B+19.4%	$1.1B+4.2%	$1.0B+10.0%	$947.7M+9.8%	$863.5M+27.4%	$677.8M+8.7%	$623.3M+9.6%	$568.5M+8.9%	$521.9M-1.1%	$527.8M+8.5%	$486.5M
R&D Expenses	$360.4M0.0%	$360.6M+11.7%	$322.7M+5.4%	$306.1M+12.9%	$271.2M+24.3%	$218.2M+12.6%	$193.7M+5.4%	$183.8M+1.5%	$181.1M+28.0%	$141.5M+10.2%	$128.5M+4.3%	$123.1M+6.7%	$115.4M-4.9%	$121.4M+11.2%	$109.1M
SG&A Expenses	$288.8M+4.3%	$276.9M+9.8%	$252.3M+2.3%	$246.5M+9.4%	$225.4M+24.7%	$180.7M+7.6%	$168.0M+9.6%	$153.3M+18.8%	$129.1M+10.7%	$116.6M+29.0%	$90.3M+8.4%	$83.4M-3.6%	$86.5M-10.1%	$96.1M+0.5%	$95.7M
Operating Income	$645.8M+18.3%	$546.0M+25.4%	$435.2M+29.9%	$335.2M+27.0%	$263.9M+9.0%	$242.0M+1.4%	$238.7M+20.8%	$197.6M+31.7%	$150.1M+11.8%	$134.2M-19.2%	$166.1M+56.3%	$106.3M+40.9%	$75.5M+65.4%	$45.6M-22.7%	$59.0M
EBITDA	$844.8M+12.5%	$751.0M+24.6%	$602.6M+17.8%	$511.7M+14.2%	$448.0M+5.6%	$424.1M+2.9%	$411.9M+16.1%	$354.8M+15.8%	$306.4M+44.5%	$212.0M-5.4%	$224.1M+24.7%	$179.6M+7.7%	$166.8M+18.2%	$141.1M+12.0%	$126.0M
Interest Expense	$0-100.0%	$46K-95.8%	$1.1M-2.3%	$1.1M-88.8%	$10.1M+29.5%	$7.8M-33.5%	$11.7M+4.3%	$11.2M+17.0%	$9.6M+414.8%	$1.9M+2719.7%	$66K-9.6%	$73K-59.9%	$182K+76.7%	$103K-37.6%	$165K
Income Tax	$91.9M-43.3%	$162.2M+35.9%	$119.4M+50.4%	$79.4M+91.8%	$41.4M+1.4%	$40.8M-15.6%	$48.4M+76.7%	$27.4M+300.8%	-$13.6M-163.7%	$21.4M-30.6%	$30.8M+211.2%	$9.9M-63.2%	$26.9M+292.3%	-$14.0M-213.0%	$12.4M
Net Income	$612.1M+39.3%	$439.5M+30.6%	$336.5M+26.9%	$265.1M+32.8%	$199.6M+1.5%	$196.7M+5.8%	$185.9M+16.7%	$159.3M+11.2%	$143.3M+22.6%	$116.9M-54.8%	$258.8M+151.1%	$103.1M+86.5%	$55.3M-18.6%	$67.9M+18.6%	$57.3M
EPS (Basic)	$9.82+40.9%	$6.97+31.0%	$5.32+27.6%	$4.17+32.4%	$3.15+0.6%	$3.13+4.7%	$2.99+15.0%	$2.60+9.7%	$2.37+20.9%	$1.96-54.9%	$4.35+150.0%	$1.74+89.1%	$0.92-17.1%	$1.11+22.0%	$0.91
EPS (Diluted)	$9.67+43.0%	$6.76+32.3%	$5.11+27.8%	$4.00+34.2%	$2.980.0%	$2.98+3.5%	$2.88+14.3%	$2.52+9.1%	$2.31+20.3%	$1.92-54.5%	$4.22+149.7%	$1.69+89.9%	$0.89-18.3%	$1.09+22.5%	$0.89
Diluted Shares (Avg)	63M-3.3%	66M-1.1%	66M-0.3%	66M-0.6%	67M+1.4%	66M+2.0%	65M+2.1%	63M+1.9%	62M+101676.0%	61,035-0.4%	61,281+0.6%	60,895-1.5%	61,830-0.7%	62,261	N/A

Metric	Q4'2510-K	Q4'2410-K	Q4'2310-K	Q4'2210-K	Q4'2110-K	Q4'2010-K	Q4'1910-K	Q4'1810-K

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

NICE Balance Sheet

NICE quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$5.1B-3.6%	$5.3B+3.5%	$5.1B+5.4%	$4.9B+3.1%	$4.7B+11.3%	$4.2B+17.3%	$3.6B+12.6%	$3.2B+12.7%	$2.8B+8.1%	$2.6B+42.3%	$1.8B+13.3%	$1.6B-1.5%	$1.7B-0.2%	$1.7B+5.0%	$1.6B
Current Assets	$1.4B-44.9%	$2.5B+8.3%	$2.3B-4.3%	$2.4B+5.2%	$2.3B+18.3%	$1.9B+121.8%	$875.7M+1.7%	$861.2M+24.3%	$693.1M+36.1%	$509.2M-22.3%	$655.2M+35.0%	$485.5M+5.4%	$460.6M-11.6%	$521.1M-4.1%	$543.2M
Cash & Equivalents	$379.4M-21.2%	$481.7M-5.9%	$511.8M-3.4%	$529.6M+39.9%	$378.7M-14.4%	$442.3M+93.7%	$228.3M-5.7%	$242.1M-26.3%	$328.3M+109.1%	$157.0M-51.8%	$325.9M+73.8%	$187.5M+56.8%	$119.5M+21.2%	$98.6M-51.8%	$204.4M
Short-Term Investments	$38.0M-96.7%	$1.1B+27.2%	$896.0M-14.0%	$1.0B-0.4%	$1.0B+2.4%	$1.0B+384.7%	$210.8M-13.5%	$243.7M+281.1%	$64.0M+111.1%	$30.3M-69.5%	$99.2M+50.9%	$65.7M-20.6%	$82.8M-58.6%	$200.0M+38.9%	$144.0M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	$3.4M-1.3%	$3.4M-11.7%	$3.9M-17.5%	$4.7M-23.9%	$6.2M-11.1%	$7.0M-48.2%	$13.4M-3.2%	$13.9M+3.7%	$13.4M
Accounts Receivable	$738.0M+14.6%	$644.0M+10.1%	$585.2M+12.9%	$518.5M+31.1%	$395.6M+30.5%	$303.1M-5.2%	$319.6M+11.0%	$288.0M+24.8%	$230.7M-11.3%	$260.2M+46.7%	$177.3M+13.9%	$155.6M-17.8%	$189.3M+21.8%	$155.4M+22.4%	$127.0M
Long-Term Investments	$0	$0	$0	$0	$0	$0-100.0%	$542.4M+121.4%	$245.0M+84.5%	$132.8M+34.5%	$98.7M-75.5%	$403.2M+63.4%	$246.7M+2.5%	$240.8M+64.7%	$146.2M-31.7%	$214.1M
Goodwill	$2.4B+31.9%	$1.8B+1.5%	$1.8B+12.7%	$1.6B+0.6%	$1.6B+6.9%	$1.5B+9.1%	$1.4B+0.9%	$1.4B+3.6%	$1.3B+2.6%	$1.3B+97.3%	$651.1M-1.3%	$659.7M-1.6%	$670.2M-3.6%	$695.0M+14.1%	$609.2M
Total Liabilities	$1.2B-27.9%	$1.7B-4.0%	$1.8B-2.0%	$1.8B-3.9%	$1.9B+13.0%	$1.7B+23.4%	$1.4B+13.6%	$1.2B+8.7%	$1.1B-2.2%	$1.1B+157.9%	$434.5M+3.6%	$419.5M-7.2%	$452.3M-3.7%	$469.9M+11.0%	$423.2M
Current Liabilities	$887.6M-39.8%	$1.5B+31.6%	$1.1B-1.8%	$1.1B-10.1%	$1.3B+21.6%	$1.0B+11.0%	$941.0M+50.6%	$624.9M+19.4%	$523.4M+10.7%	$472.8M+24.8%	$378.8M+0.1%	$378.4M-1.5%	$384.2M+0.2%	$383.4M+3.7%	$369.6M
Non-Current Liabilities	$341.9M+56.6%	$218.3M-66.0%	$642.8M-2.3%	$657.8M+9.1%	$602.9M+0.5%	$600.0M+45.7%	$411.7M-27.2%	$565.8M-1.1%	$572.2M-11.7%	$647.7M+1064.5%	$55.6M+35.3%	$41.1M-39.6%	$68.1M-21.2%	$86.4M+61.4%	$53.6M
Long-Term Debt	N/A	$0-100.0%	$457.1M+0.4%	$455.4M+6.1%	$429.3M+1.9%	$421.3M+97.5%	$213.3M-53.2%	$456.0M+1.9%	$447.6M+0.8%	$444.0M	N/A	N/A	N/A	N/A	N/A
Total Equity	$3.9B+8.0%	$3.6B+7.4%	$3.3B+9.8%	$3.0B+7.7%	$2.8B+10.2%	$2.6B+13.6%	$2.3B+11.9%	$2.0B+15.3%	$1.7B+15.8%	$1.5B+6.8%	$1.4B+16.6%	$1.2B+0.7%	$1.2B+1.2%	$1.2B+2.8%	$1.2B
Retained Earnings	$3.3B+22.7%	$2.7B+19.4%	$2.3B+17.5%	$1.9B+16.5%	$1.7B+13.7%	$1.5B+15.6%	$1.3B+17.3%	$1.1B+26.0%	$850.8M+19.7%	$710.9M+12.5%	$632.2M+53.6%	$411.6M+18.7%	$346.7M+8.2%	$320.4M+26.9%	$252.5M

Metric	Q4'2510-K	Q4'2410-K	Q4'2310-K	Q4'2210-K	Q4'2110-K	Q4'2010-K	Q4'1910-K	Q4'1810-K
Total Assets	$5.1B-3.6%	$5.3B+3.5%	$5.1B+5.4%	$4.9B+3.1%	$4.7B+11.3%	$4.2B+17.3%	$3.6B+12.6%	$3.2B+12.7%
Current Assets	$1.4B-44.9%	$2.5B+8.3%	$2.3B-4.3%	$2.4B+5.2%	$2.3B+18.3%	$1.9B+121.8%	$875.7M+1.7%	$861.2M+24.3%
Cash & Equivalents	$379.4M-21.2%	$481.7M-5.9%	$511.8M-3.4%	$529.6M+39.9%	$378.7M-14.4%	$442.3M+93.7%	$228.3M-5.7%	$242.1M-26.3%
Short-Term Investments	$38.0M-96.7%	$1.1B+27.2%	$896.0M-14.0%	$1.0B-0.4%	$1.0B+2.4%	$1.0B+384.7%	$210.8M-13.5%	$243.7M+281.1%
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	$3.4M-1.3%	$3.4M-11.7%
Accounts Receivable	$738.0M+14.6%	$644.0M+10.1%	$585.2M+12.9%	$518.5M+31.1%	$395.6M+30.5%	$303.1M-5.2%	$319.6M+11.0%	$288.0M+24.8%
Long-Term Investments	$0	$0	$0	$0	$0	$0-100.0%	$542.4M+121.4%	$245.0M+84.5%
Goodwill	$2.4B+31.9%	$1.8B+1.5%	$1.8B+12.7%	$1.6B+0.6%	$1.6B+6.9%	$1.5B+9.1%	$1.4B+0.9%	$1.4B+3.6%
Total Liabilities	$1.2B-27.9%	$1.7B-4.0%	$1.8B-2.0%	$1.8B-3.9%	$1.9B+13.0%	$1.7B+23.4%	$1.4B+13.6%	$1.2B+8.7%
Current Liabilities	$887.6M-39.8%	$1.5B+31.6%	$1.1B-1.8%	$1.1B-10.1%	$1.3B+21.6%	$1.0B+11.0%	$941.0M+50.6%	$624.9M+19.4%
Non-Current Liabilities	$341.9M+56.6%	$218.3M-66.0%	$642.8M-2.3%	$657.8M+9.1%	$602.9M+0.5%	$600.0M+45.7%	$411.7M-27.2%	$565.8M-1.1%
Long-Term Debt	N/A	$0-100.0%	$457.1M+0.4%	$455.4M+6.1%	$429.3M+1.9%	$421.3M+97.5%	$213.3M-53.2%	$456.0M+1.9%
Total Equity	$3.9B+8.0%	$3.6B+7.4%	$3.3B+9.8%	$3.0B+7.7%	$2.8B+10.2%	$2.6B+13.6%	$2.3B+11.9%	$2.0B+15.3%
Retained Earnings	$3.3B+22.7%	$2.7B+19.4%	$2.3B+17.5%	$1.9B+16.5%	$1.7B+13.7%	$1.5B+15.6%	$1.3B+17.3%	$1.1B+26.0%

NICE Cash Flow Statement

NICE quarterly cash flow statement

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$716.5M-13.9%	$832.6M+48.3%	$561.4M+17.0%	$479.7M+3.9%	$461.8M-3.8%	$480.3M+28.4%	$374.2M-5.7%	$396.6M+0.5%	$394.7M+72.9%	$228.2M-9.6%	$252.3M+38.4%	$182.3M+46.7%	$124.3M-8.4%	$135.6M-12.1%	$154.4M
Depreciation & Amortization	$199.0M-2.9%	$205.0M+22.5%	$167.4M-5.2%	$176.5M-4.1%	$184.1M+1.1%	$182.0M+5.1%	$173.2M+10.2%	$157.1M+0.5%	$156.3M+100.9%	$77.8M+34.2%	$58.0M-21.0%	$73.3M-19.7%	$91.4M-4.3%	$95.5M+42.6%	$67.0M
Stock-Based Compensation	$146.0M-19.8%	$182.1M+3.1%	$176.7M-3.3%	$182.7M+19.4%	$153.0M+50.5%	$101.7M+25.7%	$80.9M+20.3%	$67.2M+18.0%	$57.0M+40.5%	$40.5M+42.5%	$28.5M-4.6%	$29.8M+13.3%	$26.3M+11.4%	$23.6M+11.6%	$21.2M
Capital Expenditures	$18.9M-45.9%	$35.0M+19.7%	$29.2M-8.4%	$31.9M+28.8%	$24.8M+2.4%	$24.2M-11.4%	$27.3M-13.2%	$31.4M-21.2%	$39.9M+46.2%	$27.3M+64.4%	$16.6M-0.8%	$16.7M-17.3%	$20.2M-29.5%	$28.7M+65.8%	$17.3M
Free Cash Flow	$697.6M-12.5%	$797.7M+49.9%	$532.2M+18.8%	$447.8M+2.5%	$437.0M-4.2%	$456.1M+31.5%	$346.9M-5.0%	$365.2M+2.9%	$354.8M+76.6%	$200.9M-14.8%	$235.7M+42.4%	$165.5M+59.1%	$104.0M-2.7%	$106.9M-22.0%	$137.1M
Investing Cash Flow	$160.0M+140.3%	-$397.4M-35.4%	-$293.6M-92.7%	-$152.4M+41.7%	-$261.5M+43.8%	-$465.1M-35.1%	-$344.3M+25.3%	-$460.8M-116.3%	-$213.0M+73.4%	-$800.0M-2717.7%	-$28.4M	N/A	N/A	-$164.4M-1840.4%	$9.4M
Financing Cash Flow	-$984.3M-115.6%	-$456.6M-57.3%	-$290.3M-76.5%	-$164.5M+37.2%	-$261.8M-233.0%	$196.8M+561.4%	-$42.7M-162.3%	-$16.3M-9.7%	-$14.8M-103.7%	$405.4M+610.7%	-$79.4M	N/A	N/A	-$76.6M-11.3%	-$68.8M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0-100.0%	$9.6M-74.8%	$38.2M-0.1%	$38.2M+0.3%	$38.1M+31.5%	$29.0M	N/A	N/A
Share Buybacks	$488.9M+32.4%	$369.2M+28.0%	$288.4M+99.0%	$144.9M+98.1%	$73.2M+51.6%	$48.3M+2.1%	$47.3M+81.8%	$26.0M+6.5%	$24.4M-44.0%	$43.6M-36.2%	$68.4M-27.5%	$94.3M+18.7%	$79.4M-25.8%	$107.0M+11.6%	$95.9M

Metric	Q4'2510-K	Q4'2410-K	Q4'2310-K	Q4'2210-K	Q4'2110-K	Q4'2010-K	Q4'1910-K	Q4'1810-K

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

NICE Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NICE quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	66.4%-0.3pp	66.8%-0.9pp	67.7%-1.0pp	68.7%+1.2pp	67.5%+1.6pp	65.9%-0.3pp	66.2%+0.6pp	65.6%+0.8pp	64.8%-1.9pp	66.7%-0.5pp	67.3%+2.1pp	65.2%+1.7pp	63.5%+3.5pp	60.0%-1.2pp	61.3%
Operating Margin	21.9%+2.0pp	20.0%+1.6pp	18.3%+2.9pp	15.4%+1.6pp	13.7%-1.0pp	14.7%-0.5pp	15.2%+1.5pp	13.7%+2.4pp	11.3%-1.9pp	13.2%-4.7pp	17.9%+5.7pp	12.2%+3.0pp	9.2%+4.0pp	5.2%-2.2pp	7.4%
Net Margin	20.8%+4.7pp	16.1%+1.9pp	14.1%+2.0pp	12.2%+1.8pp	10.4%-1.5pp	11.9%+0.1pp	11.8%+0.8pp	11.0%+0.3pp	10.8%-0.7pp	11.5%-16.4pp	27.9%+16.1pp	11.8%+5.1pp	6.7%-1.0pp	7.7%+0.5pp	7.2%
Return on Equity	15.8%+3.6pp	12.2%+2.2pp	10.1%+1.4pp	8.7%+1.7pp	7.1%-0.6pp	7.7%-0.6pp	8.2%+0.3pp	7.9%-0.3pp	8.2%+0.5pp	7.7%-10.6pp	18.3%+9.8pp	8.5%+3.9pp	4.6%-1.1pp	5.7%+0.8pp	4.9%
Return on Assets	12.0%+3.7pp	8.3%+1.7pp	6.6%+1.1pp	5.5%+1.2pp	4.2%-0.4pp	4.7%-0.5pp	5.1%+0.2pp	5.0%-0.1pp	5.0%+0.6pp	4.4%-9.6pp	14.0%+7.7pp	6.3%+3.0pp	3.3%-0.8pp	4.1%+0.5pp	3.6%
Current Ratio	1.55-0.1x	1.70-0.4x	2.06-0.1x	2.12+0.3x	1.810.0x	1.86+0.9x	0.93-0.4x	1.38+0.1x	1.32+0.2x	1.08-0.7x	1.73+0.4x	1.28+0.1x	1.20-0.2x	1.36-0.1x	1.47
Debt-to-Equity	0.32+0.3x	0.00-0.1x	0.140.0x	0.150.0x	0.150.0x	0.16+0.1x	0.09-0.1x	0.230.0x	0.260.0x	0.290.0x	0.310.0x	0.350.0x	0.380.0x	0.390.0x	0.37
Asset Turnover	0.58+0.1x	0.52+0.1x	0.460.0x	0.450.0x	0.410.0x	0.390.0x	0.440.0x	0.450.0x	0.47+0.1x	0.39-0.1x	0.500.0x	0.530.0x	0.500.0x	0.530.0x	0.50
FCF Margin	23.7%-5.5pp	29.2%+6.8pp	22.4%+1.9pp	20.5%-2.2pp	22.8%-4.9pp	27.7%+5.6pp	22.0%-3.2pp	25.3%-1.3pp	26.6%+6.8pp	19.8%-5.6pp	25.4%+6.5pp	19.0%+6.3pp	12.7%+0.5pp	12.2%-5.1pp	17.3%

Metric	Q4'2510-K	Q4'2410-K	Q4'2310-K	Q4'2210-K	Q4'2110-K	Q4'2010-K	Q4'1910-K	Q4'1810-K
Current Ratio	1.55-0.1x	1.70-0.4x	2.06-0.1x	2.12+0.3x	1.810.0x	1.86+0.9x	0.93-0.4x	1.38+0.1x
Debt-to-Equity	0.32+0.3x	0.00-0.1x	0.140.0x	0.150.0x	0.150.0x	0.16+0.1x	0.09-0.1x	0.230.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
NICE Ltd NICE	FY2025	$2.9B	$612.1M	20.8%	$6.8B	72/100
Open Text Corp OTEX	FY2026	$5.2B	$643.0M	12.3%	$5.4B	48/100
Commault Systems, Inc. CVLT	FY2026	$1.2B	$70.7M	6.0%	$6.4B	61/100
Pegasystems Inc PEGA	FY2025	$1.7B	$393.4M	22.5%	$5.7B	60/100
Paylocity Holding Corporation PCTY	FY2026	$1.8B	$269.7M	15.2%	$7.8B	75/100

Where NICE Ltd Ranks

Frequently Asked Questions

What is NICE Ltd's annual revenue?

NICE Ltd (NICE) reported $2.9B in total revenue for fiscal year 2025. This represents a 7.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is NICE Ltd's revenue growing?

NICE Ltd (NICE) revenue grew by 7.7% year-over-year, from $2.7B to $2.9B in fiscal year 2025.

Is NICE Ltd profitable?

Yes, NICE Ltd (NICE) reported a net income of $612.1M in fiscal year 2025, with a net profit margin of 20.8%.

What is NICE Ltd's EBITDA?

NICE Ltd (NICE) had EBITDA of $844.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is NICE Ltd's gross margin?

NICE Ltd (NICE) had a gross margin of 66.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is NICE Ltd's operating margin?

NICE Ltd (NICE) had an operating margin of 21.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is NICE Ltd's net profit margin?

NICE Ltd (NICE) had a net profit margin of 20.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is NICE Ltd's return on equity (ROE)?

NICE Ltd (NICE) has a return on equity of 15.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is NICE Ltd's free cash flow?

NICE Ltd (NICE) generated $697.6M in free cash flow during fiscal year 2025. This represents a -12.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is NICE Ltd's operating cash flow?

NICE Ltd (NICE) generated $716.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are NICE Ltd's total assets?

NICE Ltd (NICE) had $5.1B in total assets as of fiscal year 2025, including both current and long-term assets.

What are NICE Ltd's capital expenditures?

NICE Ltd (NICE) invested $18.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does NICE Ltd spend on research and development?

NICE Ltd (NICE) invested $360.4M in research and development during fiscal year 2025.

Does NICE Ltd buy back shares?

Yes, NICE Ltd (NICE) spent $488.9M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does NICE Ltd have outstanding?

NICE Ltd (NICE) had 60M shares outstanding as of fiscal year 2025.

What is NICE Ltd's current ratio?

NICE Ltd (NICE) had a current ratio of 1.55 as of fiscal year 2025, which is generally considered healthy.

What is NICE Ltd's debt-to-equity ratio?

NICE Ltd (NICE) had a debt-to-equity ratio of 0.32 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is NICE Ltd's return on assets (ROA)?

NICE Ltd (NICE) had a return on assets of 12.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is NICE Ltd's P/E ratio?

NICE Ltd (NICE) trades at 11.0x earnings, its market capitalization divided by net income of $612.1M net income, FY2025. The market capitalization is $6.8B as of Oct 7, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is NICE Ltd's price-to-sales ratio?

NICE Ltd (NICE) trades at 2.3x sales, its market capitalization divided by revenue of $2.9B revenue, FY2025. The market capitalization is $6.8B as of Oct 7, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is NICE Ltd's Altman Z-Score?

NICE Ltd (NICE) has an Altman Z-Score of 5.32, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is NICE Ltd's Piotroski F-Score?

NICE Ltd (NICE) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are NICE Ltd's earnings high quality?

NICE Ltd (NICE) has an earnings quality ratio of 1.17x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is NICE Ltd?

NICE Ltd (NICE) scores 72 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.